|
1
|
Nikitovic D, Katonis P, Tsatsakis A,
Karamanos NK and Tzanakakis GN: Lumican, a small leucine-rich
proteoglycan. IUBMB Life. 60:818–823. 2008. View Article : Google Scholar
|
|
2
|
Iozzo RV: Matrix proteoglycans: from
molecular design to cellular function. Annu Rev Biochem.
67:609–652. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grover J, Chen XN, Korenberg JR and
Roughley PJ: The human lumican gene. Organization, chromosomal
location, and expression in articular cartilage. J Biol Chem.
270:21942–21949. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chakravarti S, Stallings RL, SundarRaj N,
Cornuet PK and Hassell JR: Primary structure of human lumican
(keratan sulfate proteoglycan) and localization of the gene (LUM)
to chromosome 12q21.3–q22. Genomics. 27:481–488. 1995.PubMed/NCBI
|
|
5
|
Naito Z: Role of the small leucine-rich
proteoglycan (SLRP) family in pathological lesions and cancer cell
growth. J Nippon Med Sch. 72:137–145. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rada JA, Cornuet PK and Hassell JR:
Regulation of corneal collagen fibrillogenesis in vitro by corneal
proteoglycan (lumican and decorin) core proteins. Exp Eye Res.
56:635–648. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Svensson L, Närlid I and Oldberg A:
Fibromodulin and lumican bind to the same region on collagen type I
fibrils. FEBS Lett. 470:178–182. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chakravarti S: Functions of lumican and
fibromodulin: lessons from knockout mice. Glycoconj J. 19:287–293.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vogel KG, Paulsson M and Heinegård D:
Specific inhibition of type I and type II collagen fibrillogenesis
by the small proteoglycan of tendon. Biochem J. 223:587–597.
1984.PubMed/NCBI
|
|
10
|
Chakravarti S, Magnuson T, Lass JH, Jepsen
KJ, LaMantia C and Carroll H: Lumican regulates collagen fibril
assembly: skin fragility and corneal opacity in the absence of
lumican. J Cell Biol. 141:1277–1286. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jepsen KJ, Wu F, Peragallo JH, et al: A
syndrome of joint laxity and impaired tendon integrity in lumican-
and fibromodulin-deficient mice. J Biol Chem. 277:35532–35540.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Blochberger TC, Cornuet PK and Hassell JR:
Isolation and partial characterization of lumican and decorin from
adult chicken corneas. A keratan sulfate-containing isoform of
decorin is developmentally regulated. J Biol Chem. 267:20613–20619.
1992.
|
|
13
|
Dolhnikoff M, Morin J, Roughley PJ and
Ludwig MS: Expression of lumican in human lungs. Am J Respir Cell
Mol Biol. 19:582–587. 1998. View Article : Google Scholar
|
|
14
|
Qin H, Ishiwata T and Asano G: Effects of
the extracellular matrix on lumican expression in rat aortic smooth
muscle cells in vitro. J Pathol. 195:604–608. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baba H, Ishiwata T, Takashi E, Xu G and
Asano G: Expression and localization of lumican in the ischemic and
reperfused rat heart. Jpn Circ J. 65:445–450. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Onda M, Ishiwata T, Kawahara K, Wang R,
Naito Z and Sugisaki Y: Expression of lumican in thickened intima
and smooth muscle cells in human coronary atherosclerosis. Exp Mol
Pathol. 72:142–149. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ping Lu Y, Ishiwata T and Asano G: Lumican
expression in alpha cells of islets in pancreas and pancreatic
cancer cells. J Pathol. 196:324–330. 2002.PubMed/NCBI
|
|
18
|
Lu YP, Ishiwata T, Kawahara K, et al:
Expression of lumican in human colorectal cancer cells. Pathol Int.
52:519–526. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kelemen LE, Couch FJ, Ahmed S, et al:
Genetic variation in stromal proteins decorin and lumican with
breast cancer: investigations in two case-control studies. Breast
Cancer Res. 10:R982008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Troup S, Njue C, Kliewer EV, et al:
Reduced expression of the small leucine-rich proteoglycans,
lumican, and decorin is associated with poor outcome in
node-negative invasive breast cancer. Clin Cancer Res. 9:207–214.
2003.PubMed/NCBI
|
|
21
|
Ishiwata T, Cho K, Kawahara K, et al: Role
of lumican in cancer cells and adjacent stromal tissues in human
pancreatic cancer. Oncol Rep. 18:537–543. 2007.PubMed/NCBI
|
|
22
|
Vuillermoz B, Khoruzhenko A, D’Onofrio MF,
et al: The small leucine-rich proteoglycan lumican inhibits
melanoma progression. Exp Cell Res. 296:294–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shinji S, Tajiri T, Ishiwata T, Seya T,
Tanaka N and Naito Z: Different expression levels of lumican in
human carcinoid tumor and neuroendocrine cell carcinoma. Int J
Oncol. 26:873–880. 2005.PubMed/NCBI
|
|
24
|
Seya T, Tanaka N, Shinji S, et al: Lumican
expression in advanced colorectal cancer with nodal metastasis
correlates with poor prognosis. Oncol Rep. 16:1225–1230.
2006.PubMed/NCBI
|
|
25
|
Matsuda Y, Yamamoto T, Kudo M, et al:
Expression and roles of lumican in lung adenocarcinoma and squamous
cell carcinoma. Int J Oncol. 33:1177–1185. 2008.PubMed/NCBI
|
|
26
|
Leygue E, Snell L, Dotzlaw H, et al:
Expression of lumican in human breast carcinoma. Cancer Res.
58:1348–1352. 1998.
|
|
27
|
Naito Z, Ishiwata T, Kurban G, et al:
Expression and accumulation of lumican protein in uterine cervical
cancer cells at the periphery of cancer nests. Int J Oncol.
20:943–948. 2002.PubMed/NCBI
|
|
28
|
Yamamoto T, Matsuda Y, Kawahara K,
Ishiwata T and Naito Z: Secreted 70kDa lumican stimulates growth
and inhibits invasion of human pancreatic cancer. Cancer Lett.
320:31–39. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bluemlein K and Ralser M: Monitoring
protein expression in whole-cell extracts by targeted label- and
standard-free LC-MS/MS. Nat Protoc. 6:859–869. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Old WM, Meyer-Arendt K, Aveline-Wolf L, et
al: Comparison of label-free methods for quantifying human proteins
by shotgun proteomics. Mol Cell Proteomics. 4:1487–1502. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zybailov B, Coleman MK, Florens L and
Washburn MP: Correlation of relative abundance ratios derived from
peptide ion chromatograms and spectrum counting for quantitative
proteomic analysis using stable isotope labeling. Analytical
chemistry. 77:6218–6224. 2005. View Article : Google Scholar
|
|
32
|
Dennis G Jr, Sherman BT, Hosack DA, et al:
DAVID: Database for Annotation, Visualization, and Integrated
Discovery. Genome Biol. 4:P32003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
34
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009.PubMed/NCBI
|
|
35
|
Lundgren DH, Hwang SI, Wu L and Han DK:
Role of spectral counting in quantitative proteomics. Expert Rev
Proteomics. 7:39–53. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vermes I, Haanen C, Steffens-Nakken H and
Reutelingsperger C: A novel assay for apoptosis. Flow cytometric
detection of phosphatidylserine expression on early apoptotic cells
using fluorescein labelled Annexin V. J Immunol Methods. 184:39–51.
1995. View Article : Google Scholar
|
|
37
|
Aubry JP, Blaecke A, Lecoanet-Henchoz S,
et al: Annexin V used for measuring apoptosis in the early events
of cellular cytotoxicity. Cytometry. 37:197–204. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vij N, Roberts L, Joyce S and Chakravarti
S: Lumican suppresses cell proliferation and aids Fas-Fas ligand
mediated apoptosis: implications in the cornea. Exp Eye Res.
78:957–971. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Brezillon S, Venteo L, Ramont L, et al:
Expression of lumican, a small leucine-rich proteoglycan with
antitumour activity, in human malignant melanoma. Clin Exp
Dermatol. 32:405–416. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Williams KE, Fulford LA and Albig AR:
Lumican reduces tumor growth via induction of fas-mediated
endothelial cell apoptosis. Cancer Microenviron. 4:115–126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yamasaki M, Nomura T, Sato F and Mimata H:
Metallothionein is up-regulated under hypoxia and promotes the
survival of human prostate cancer cells. Oncol Rep. 18:1145–1153.
2007.PubMed/NCBI
|
|
42
|
Liang JY, Liu YY, Zou J, Franklin RB,
Costello LC and Feng P: Inhibitory effect of zinc on human
prostatic carcinoma cell growth. Prostate. 40:200–207. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Feng P, Li TL, Guan ZX, Franklin RB and
Costello LC: Direct effect of zinc on mitochondrial apoptogenesis
in prostate cells. Prostate. 52:311–318. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ryu HH, Jung S, Jung TY, et al: Role of
metallothionein 1E in the migration and invasion of human glioma
cell lines. Int J Oncol. 41:1305–1313. 2012.PubMed/NCBI
|
